Stage II-IV hormone receptor+, breast cancer diagnosis
Post-menopausal (defined as at least 1-year post menses, on ovarian suppression medication, or s/p oophorectomy)
Within 4 weeks before or 12 weeks after starting initial systemic therapies (e.g. chemotherapy, targeted therapies such as CDK4/6 inhibitors, endocrine therapy)
Ability to access and use internet resources, including video calls using Zoom platform
English speaking
You may not be if
History of dementia, stroke, traumatic brain injury, brain metastasis or other conditions that could lead to cognitive impairment
MIND diet score \>8
Unwilling/unable to eat \>2 types of MIND food
Receiving insulin therapy for diabetes
Diagnosis of triple negative breast cancer
Unable to give informed consent.
Clareo Health | Pilot Study of a MIND Diet Intervention in Women Undergoing Active Treatment for Breast Cancer
